At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,079 enrolled
Drug / intervention
MiraLAX +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Comparison of Five Low Volume Bowel Preparations for Colonoscopy
In Brief
A Phase 4 clinical trial evaluating MiraLAX, Gatorade, and 2 other interventions for Bowel Preparation for Colonoscopy. Completed, enrolled 1,079 participants across 1 site.
Detailed Summary
The purpose of this investigation is to compare 3 versions of MiraLAX/Gatorade, MoviPrep and SUPREP to see which preparation cleanses the colon best and which preparation is best tolerated.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBowel Preparation for Colonoscopy
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
First PostedNov 2012
Primary CompletionSep 2014
TodayJul 2026
First PostedNov 1, 2012
Enrollment StartOct 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 13.7 years ago
Interventions
MiraLAXdrug
MiraLAX consumed as described in each arm.
Gatoradeother
Gatorade consumed as described in each arm.
MoviPrepdrug
MoviPrep consumed as described in each arm.
SUPREPdrug
SUPREP consumed as described in each arm.